GO:1904200 iodide transmembrane transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904200 iodide transmembrane transport is the biological process by which iodide ions cross cellular membranes, a critical step in thyroid hormone synthesis and iodide homeostasis.
• The sodium/iodide symporter (SLC5A5/NIS) is the primary mediator of active iodide uptake in the thyroid and other tissues, coupling iodide transport to the sodium gradient.
• Pendrin (SLC26A4) and SLC26A7 are anion exchangers that mediate iodide efflux and transport across the apical membrane of thyrocytes and other epithelia.
• Mutations in SLC5A5 cause iodide transport defect (ITD), a congenital hypothyroidism disorder, and the Y348D mutation renders the protein intrinsically inactive and impairs plasma membrane targeting.
• Iodide transmembrane transport is relevant beyond the thyroid, with NIS expressed in extra-thyroidal tissues including salivary glands, stomach, and breast, influencing iodide distribution and cancer biology.
• Experimental approaches to study iodide transport include electrophysiology, radioactive iodide uptake assays, structural biology, and CRISPR-based gene editing of transport proteins.
Description
Iodide transmembrane transport (GO:1904200) is the process in which iodide ions (I-) are transported across a biological membrane. This process is fundamental to thyroid physiology because iodide is an essential substrate for the synthesis of thyroid hormones, which regulate metabolism, growth, and development. The transport of iodide is mediated by specialized membrane proteins that facilitate its uptake from the bloodstream into cells and its subsequent efflux or translocation across epithelial barriers. Research on iodide transmembrane transport has revealed a complex interplay of transporters, including the sodium/iodide symporter (NIS, encoded by SLC5A5) and members of the SLC26 anion exchanger family such as pendrin (SLC26A4) and SLC26A7. These proteins are not only critical for normal thyroid function but are also implicated in disease states ranging from congenital hypothyroidism to cancer. Understanding the molecular mechanisms of iodide transport is therefore essential for developing diagnostic and therapeutic strategies targeting these pathways. Recent structural and functional studies have provided detailed insights into how these transporters recognize and translocate iodide, revealing distinct mechanisms for active uptake versus passive exchange. This article synthesizes current knowledge on the genes, mechanisms, and research methods associated with GO:1904200, providing a resource for researchers investigating iodide transport in health and disease.
iodide transmembrane transport At A Glance
| GO ID | GO:1904200 |
|---|---|
| GO term | iodide transmembrane transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Transport of iodide ions across cellular membranes |
| Key transporters | SLC5A5 (NIS), SLC26A4 (pendrin), SLC26A7 |
| Physiological role | Thyroid hormone synthesis, iodide homeostasis, extra-thyroidal iodide distribution |
| Disease relevance | Iodide transport defect, congenital hypothyroidism, thyroid cancer |
| Research methods | Radioactive iodide uptake, electrophysiology, structural biology, CRISPR editing |
What Is GO:1904200?
GO:1904200 iodide transmembrane transport is defined as the process in which iodide is transported across a membrane. This biological process encompasses the movement of iodide ions from one side of a lipid bilayer to the other, mediated by specific transport proteins. It includes both active transport, such as sodium-coupled iodide uptake, and passive or exchange-mediated transport, such as anion exchange.
Why Is iodide transmembrane transport Important in Cell Biology?
Iodide transmembrane transport is essential for thyroid hormone biosynthesis and overall iodide homeostasis in the body. Defects in this process lead to iodide transport defect (ITD), a condition characterized by congenital hypothyroidism, and are also implicated in thyroid cancer and other diseases. Beyond the thyroid, iodide transporters are expressed in extra-thyroidal tissues, where they influence iodide distribution and may affect cancer diagnostics and treatment. Understanding the molecular mechanisms of iodide transport is therefore critical for both basic physiology and clinical applications.
• Required for thyroid hormone synthesis; iodide must be transported into thyrocytes for organification.
• Mutations in SLC5A5 cause iodide transport defect (ITD) and congenital hypothyroidism.
• Pendrin (SLC26A4) mutations are associated with Pendred syndrome and enlarged vestibular aqueduct.
• Extra-thyroidal NIS expression in salivary glands, stomach, and breast affects iodide distribution and cancer imaging.
• Iodide transport is a target for cancer therapy, particularly in thyroid cancer using radioactive iodide.
• Structural studies of SLC26 transporters reveal mechanisms of anion exchange and small-molecule inhibition.
• Iodide transport can be studied using synthetic anion transporters, providing insights into halide selectivity.
• Transmembrane iodide transport in kidney proximal tubules contributes to iodide clearance.
What Happens During iodide transmembrane transport?
Active iodide uptake by the sodium/iodide symporter (NIS)
In simple terms: The sodium/iodide symporter pulls iodide into cells by using the energy from sodium gradients.
The sodium/iodide symporter (NIS, encoded by SLC5A5) is a key mediator of active iodide transport in the thyroid and other tissues. NIS couples the inward transport of sodium ions down their electrochemical gradient to the inward transport of iodide against its concentration gradient. This secondary active transport mechanism concentrates iodide in the cytoplasm of thyrocytes, a prerequisite for thyroid hormone synthesis. The Y348D mutation in NIS, which causes iodide transport defect, renders the protein intrinsically inactive and impairs its targeting to the plasma membrane. NIS is also expressed in extra-thyroidal tissues such as salivary glands, gastric mucosa, and lactating breast, where it contributes to iodide distribution.
Apical iodide efflux via pendrin (SLC26A4)
In simple terms: Pendrin helps iodide move out of thyroid cells into the follicle for hormone production.
Pendrin (SLC26A4) is an anion exchanger localized to the apical membrane of thyrocytes, where it mediates the efflux of iodide into the follicular lumen. This step is essential for the organification of iodide onto thyroglobulin, a key reaction in thyroid hormone synthesis. Structural studies of pendrin have revealed the mechanism of anion exchange and small-molecule inhibition, providing a framework for understanding how mutations in SLC26A4 lead to Pendred syndrome. Pendrin also transports other anions such as chloride and bicarbonate, and its dysfunction can disrupt iodide transport and thyroid function.
Iodide transport by SLC26A7
In simple terms: SLC26A7 is another transporter that moves iodide across membranes in various tissues.
SLC26A7 is a member of the SLC26 anion exchanger family that mediates iodide transport in the kidney, stomach, and other tissues. Recent structural studies have elucidated the substrate recognition mechanism of human SLC26A7, revealing how it binds and translocates iodide and other anions. SLC26A7 is thought to play a role in iodide homeostasis and may contribute to iodide transport in extra-thyroidal tissues. Its function is distinct from that of pendrin, although both belong to the same family and share structural similarities.
Transmembrane iodide transport in kidney proximal tubules
In simple terms: The kidneys also transport iodide across cell membranes to regulate its levels in the body.
The proximal tubule of the kidney is involved in the transmembrane transport of iodide, contributing to iodide clearance and homeostasis. Early studies using rat proximal tubules demonstrated the transport of both chloride and iodide across the tubular epithelium, indicating that iodide shares transport pathways with other halides. This process is important for regulating systemic iodide levels and may influence thyroid function by altering iodide availability.
Synthetic anion transporters for iodide
In simple terms: Scientists have designed artificial molecules that can carry iodide across membranes, helping to study the process.
Synthetic anion transporters have been developed to mimic natural iodide transport across lipid bilayers. These compounds, such as catenane-based transporters, exploit mechanical bond effects to achieve selective halide transport, including iodide. Such synthetic systems provide valuable tools for studying the fundamental principles of iodide transmembrane transport and may inspire new therapeutic approaches.
Key Genes Involved in GO:1904200 iodide transmembrane transport
The following genes encode proteins that directly mediate or regulate iodide transmembrane transport, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC5A5 | Sodium/iodide symporter (NIS); active iodide uptake | Mutations cause iodide transport defect; target for thyroid cancer imaging and therapy |
| SLC26A4 | Pendrin; apical iodide efflux and anion exchange | Mutations linked to Pendred syndrome; structural studies of anion exchange |
| SLC26A7 | Anion exchanger mediating iodide transport | Structural basis for substrate recognition; role in extra-thyroidal iodide transport |
| SLC26A3 | Chloride/iodide exchanger | Potential role in iodide transport in epithelia; not directly cited in this article |
| SLC26A6 | Anion exchanger with iodide transport activity | May contribute to iodide homeostasis; not directly cited in this article |
| SLC12A2 | Sodium-potassium-chloride cotransporter | Indirectly affects iodide transport via ion gradients; not directly cited |
| SLC4A4 | Sodium bicarbonate cotransporter | May influence iodide transport through pH regulation; not directly cited |
| CLCN5 | Chloride/proton exchanger | Potential iodide transport in kidney; not directly cited |
| ANO1 | Calcium-activated chloride channel | May transport iodide in some tissues; not directly cited |
| CFTR | Chloride channel | Can transport iodide; relevant to epithelial iodide transport; not directly cited |
| TPO | Thyroid peroxidase | Organifies iodide but not a transporter; downstream of transport |
| TG | Thyroglobulin | Accepts iodinated tyrosines; not a transporter |
| TSHR | Thyroid stimulating hormone receptor | Regulates thyroid function and iodide uptake; not directly cited |
| PAX8 | Transcription factor regulating thyroid genes | Controls expression of SLC5A5 and other thyroid genes; not directly cited |
| NKX2-1 | Thyroid transcription factor 1 | Regulates thyroid-specific gene expression; not directly cited |
| FOXE1 | Thyroid transcription factor 2 | Regulates thyroid development and gene expression; not directly cited |
| SLC26A9 | Anion transporter | Potential iodide transport in lung and other tissues; not directly cited |
| SLC22A4 | Organic cation transporter | May transport iodide in some contexts; not directly cited |
How Is iodide transmembrane transport Regulated?
Iodide transmembrane transport is regulated at multiple levels. In the thyroid, thyroid-stimulating hormone (TSH) stimulates iodide uptake by increasing NIS expression and membrane targeting. The expression of SLC5A5 is controlled by thyroid-specific transcription factors such as PAX8, NKX2-1, and FOXE1, which are not directly cited in this article but are well-established regulators. Additionally, iodide itself can regulate its own transport through a negative feedback mechanism known as the Wolff-Chaikoff effect, although this is not directly cited here. Post-translational modifications, such as glycosylation and phosphorylation, can affect NIS stability and function. In extra-thyroidal tissues, NIS expression is regulated by tissue-specific factors and hormonal signals. The activity of pendrin and SLC26A7 may be modulated by intracellular pH and anion concentrations.
iodide transmembrane transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC5A5 | Iodide transport defect, congenital hypothyroidism | Knockout or point-mutation (Y348D) in thyroid cell lines or animal models |
| SLC26A4 | Pendred syndrome, enlarged vestibular aqueduct | Knockout or knock-in of patient mutations in HEK293 or thyroid cells |
| SLC26A7 | Potential role in kidney and stomach iodide transport | Knockout in renal epithelial cells or organoids |
| SLC5A5 | Thyroid cancer, radioactive iodide resistance | Overexpression or knockout in thyroid cancer cell lines |
| SLC26A4 | Thyroid dysfunction, goiter | Knock-in of SLC26A4 mutations in mouse models |
Iodide transport defect and congenital hypothyroidism
Mutations in SLC5A5, which encodes the sodium/iodide symporter, cause iodide transport defect (ITD), a rare autosomal recessive disorder characterized by congenital hypothyroidism, goiter, and low thyroidal iodide uptake. The Y348D mutation in NIS has been shown to render the protein intrinsically inactive and impair its targeting to the plasma membrane, providing a molecular explanation for ITD. Patients with ITD require lifelong thyroid hormone replacement therapy, and early diagnosis is critical to prevent neurodevelopmental deficits.
Pendred syndrome and SLC26A4 mutations
Mutations in SLC26A4, encoding pendrin, are associated with Pendred syndrome, an autosomal recessive disorder characterized by sensorineural hearing loss and goiter. Pendrin dysfunction impairs iodide efflux into the follicular lumen, leading to thyroid dysfunction and compensatory goiter. Structural studies of pendrin have provided insights into how mutations affect anion exchange and small-molecule inhibition, offering potential avenues for therapeutic intervention.
Thyroid cancer and iodide transport
Iodide transport is directly relevant to thyroid cancer management because radioactive iodide (RAI) therapy relies on NIS-mediated uptake of iodide into thyroid cancer cells. Loss of NIS expression or function is a common feature of poorly differentiated thyroid cancers, leading to RAI resistance. Extra-thyroidal NIS expression in breast cancer and other tumors has been explored for diagnostic and therapeutic applications, although its role remains controversial.
Extra-thyroidal iodide transport and cancer
The extra-thyroidal distribution of NIS includes salivary glands, stomach, and breast, where it may influence iodide concentration and cancer biology. In breast cancer, NIS expression has been proposed as a potential target for RAI therapy, but clinical translation has been limited by low expression levels and inefficient membrane targeting. Understanding the regulation of NIS in extra-thyroidal tissues is essential for developing effective targeted therapies.
From iodide transmembrane transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC5A5 mediate active iodide uptake? | Knockout of SLC5A5 in thyroid cell lines (e.g., FRTL-5) followed by radioactive iodide uptake assay |
| How does the Y348D mutation affect NIS function? | Point mutation knock-in of Y348D in SLC5A5 in HEK293 cells, followed by membrane localization and uptake assays |
| What is the role of pendrin in iodide efflux? | Knockout of SLC26A4 in thyroid cells or organoids, measure apical iodide transport |
| Can SLC26A7 transport iodide? | Overexpression of SLC26A7 in Xenopus oocytes or HEK293 cells, measure iodide currents |
| What is the effect of NIS overexpression in cancer? | Overexpression of SLC5A5 in breast cancer cell lines, assess iodide uptake and cytotoxicity |
| How does TSH regulate iodide transport? | Knock-in of tagged NIS in thyroid cells, monitor trafficking and regulation |
How to Study the iodide transmembrane transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioactive iodide uptake | Cellular accumulation of iodide | Assessing NIS function and regulation |
| Patch-clamp electrophysiology | Ion currents mediated by transporters | Characterizing SLC26A7 and other anion exchangers |
| Cryo-electron microscopy | Three-dimensional protein structure | Determining pendrin and SLC26A7 structures |
| CRISPR knockout | Loss-of-function phenotype | Validating the role of SLC5A5 in iodide transport |
| CRISPR point mutation | Effect of specific mutations | Modeling the Y348D ITD mutation |
| Immunofluorescence | Protein localization and trafficking | Assessing NIS membrane targeting |
| RNA-seq | Transcriptional changes | Identifying regulators of iodide transport genes |
| Proteomics | Protein expression and interactions | Discovering novel iodide transport regulators |
Radioactive iodide uptake assays
Radioactive iodide uptake assays using iodine-125 or iodine-131 are the gold standard for measuring iodide transport activity in cells and tissues. These assays quantify the accumulation of radioactive iodide in cells over time, reflecting the activity of transporters such as NIS. They are widely used to study the effects of mutations, inhibitors, and regulatory factors on iodide transport.
Electrophysiology and flux studies
Electrophysiological techniques, such as patch-clamp and two-electrode voltage clamp, can measure iodide currents mediated by transporters expressed in Xenopus oocytes or mammalian cells. These methods provide real-time kinetic data on iodide transport and are particularly useful for studying anion exchangers like SLC26A7. Flux studies using radioactive tracers in isolated tubules or membrane vesicles can also assess iodide transport.
Structural biology and molecular dynamics
Cryo-electron microscopy and X-ray crystallography have been used to determine the structures of pendrin and SLC26A7, revealing the molecular basis for iodide recognition and transport. These structures, combined with molecular dynamics simulations, provide insights into substrate binding, conformational changes, and inhibition mechanisms. Such studies are essential for rational drug design targeting iodide transporters.
CRISPR-based gene editing and functional genomics
CRISPR-Cas9 knockout, point mutation, and knock-in models enable precise interrogation of genes involved in iodide transport. For example, knocking out SLC5A5 in thyroid cells abolishes iodide uptake, while introducing the Y348D mutation recapitulates the ITD phenotype. These models are invaluable for dissecting the molecular mechanisms of iodide transport and for testing therapeutic interventions.
How CRISPR Can Be Used to Study GO:1904200 iodide transmembrane transport
Knockout
CRISPR-Cas9 knockout of SLC5A5, SLC26A4, or SLC26A7 in cell lines such as FRTL-5, HEK293, or thyroid cancer cells can abolish or reduce iodide transport, providing direct evidence for their roles. Knockout models are also useful for identifying compensatory transporters and for studying the consequences of loss of function on thyroid hormone synthesis.
Point Mutation
Introducing disease-causing point mutations, such as Y348D in SLC5A5, using CRISPR base editing or homology-directed repair allows researchers to study the molecular mechanisms of iodide transport defects. These models can reveal defects in protein stability, trafficking, or intrinsic activity, as demonstrated for the Y348D mutation.
Knock-in
Knock-in of tagged versions of SLC5A5 or SLC26A4 (e.g., GFP or HA tags) enables real-time imaging of transporter localization and trafficking in live cells. Knock-in of patient-specific mutations into model organisms can recapitulate disease phenotypes and serve as platforms for drug testing.
Overexpression
Overexpression of SLC5A5 or SLC26A4 in cell lines that normally lack these transporters can confer iodide transport activity, facilitating functional studies and high-throughput screening for modulators. Overexpression models are also used to study the effects of NIS in cancer cells for potential radioiodine therapy.
How EDITGENE Supports iodide transmembrane transport Research
Researchers studying iodide transmembrane transport-related genes often need to determine whether a candidate gene is causally involved in iodide uptake, efflux, or homeostasis. EDITGENE provides comprehensive CRISPR-based services to create precise cell models for such investigations, enabling functional validation of genes like SLC5A5, SLC26A4, and SLC26A7.
Contact EDITGENE today to design your custom CRISPR model for iodide transmembrane transport research.
Frequently Asked Questions About iodide transmembrane transport
What is iodide transmembrane transport?
Iodide transmembrane transport (GO:1904200) is the biological process in which iodide ions are transported across a membrane, mediated by specific transport proteins such as the sodium/iodide symporter and anion exchangers.
What genes are involved in iodide transmembrane transport?
Key genes include SLC5A5 (encoding NIS), SLC26A4 (pendrin), and SLC26A7, which encode proteins that directly transport iodide across membranes.
What is the role of SLC5A5 in iodide transport?
SLC5A5 encodes the sodium/iodide symporter (NIS), which actively transports iodide into cells using the sodium gradient, a critical step for thyroid hormone synthesis.
How is iodide transported in the thyroid?
In the thyroid, iodide is taken up from the blood by NIS at the basolateral membrane and effluxed into the follicle by pendrin at the apical membrane, where it is organified onto thyroglobulin.
What diseases are associated with defective iodide transport?
Mutations in SLC5A5 cause iodide transport defect and congenital hypothyroidism, while SLC26A4 mutations cause Pendred syndrome.
What is the Y348D mutation in NIS?
The Y348D mutation in SLC5A5 renders the sodium/iodide symporter intrinsically inactive and impairs its targeting to the plasma membrane, leading to iodide transport defect.
How can I study iodide transmembrane transport in the lab?
Common methods include radioactive iodide uptake assays, electrophysiology, structural biology, and CRISPR-based gene editing to create knockout or mutant cell models.
What is the function of pendrin in iodide transport?
Pendrin (SLC26A4) is an anion exchanger that mediates the efflux of iodide across the apical membrane of thyrocytes, a step required for thyroid hormone synthesis.
Is iodide transport relevant to cancer?
Yes, iodide transport is relevant to thyroid cancer because radioactive iodide therapy depends on NIS-mediated uptake, and loss of NIS causes resistance; extra-thyroidal NIS expression is also studied in other cancers.
What model systems are used to study iodide transport?
Model systems include thyroid cell lines (e.g., FRTL-5), HEK293 cells, Xenopus oocytes, and animal models, often manipulated with CRISPR to knockout or mutate specific transporters.
Conclusion
Iodide transmembrane transport (GO:1904200) is a fundamental biological process required for thyroid hormone synthesis and iodide homeostasis. The coordinated action of transporters such as NIS, pendrin, and SLC26A7 ensures efficient iodide uptake and efflux, and their dysfunction leads to diseases including congenital hypothyroidism and Pendred syndrome. Continued research using advanced structural, functional, and CRISPR-based approaches will further elucidate the mechanisms of iodide transport and inform therapeutic strategies for related disorders.
References
- 1. Wang L et al.. 2024. Mechanism of anion exchange and small-molecule inhibition of pendrin.. Nat Commun 15(1):346 PMID: 38184688
- 3. Li X et al.. 2025. Structural basis for substrate recognition mechanism of human SLC26A7.. Nat Commun 16(1):7600 PMID: 40817112
- 4. De la Vieja A et al.. 2018. Role of iodide metabolism in physiology and cancer.. Endocr Relat Cancer 25(4):R225-R245 PMID: 29437784
- 5. Reyna-Neyra A et al.. 2021. The Iodide Transport Defect-Causing Y348D Mutation in the Na(+)/I(-) Symporter Renders the Protein Intrinsically Inactive and Impairs Its Targeting to the Plasma Membrane.. Thyroid 31(8):1272-1281 PMID: 33779310
- 6. Danielson BG et al.. 1970. Transmembrane transport of chloride and iodide in proximal rat tubules.. Acta Physiol Scand 78(3):339-46 PMID: 5449076
- 7. Gadisi RP et al.. 2025. The extra-thyroidal distribution of sodium iodide symporter.. Front Endocrinol (Lausanne) 16:1567405 PMID: 40678322
- 8. Min Tay H et al.. 2023. Exploiting the Catenane Mechanical Bond Effect for Selective Halide Anion Transmembrane Transport.. Angew Chem Int Ed Engl 62(47):e202312745 PMID: 37772928
